This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Oxford University Innovation Ltd, The Institute of Cancer Research: Royal Cancer Hospital. Active years: 2023-2024.
Company Filing History:
1 out of 483 
1 out of 54 
Years Active: 2023-2024
Title: Tenin Traore: Innovator in Pharmaceutical Compounds
Introduction
Tenin Traore is a notable inventor based in Saffron Walden, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating proliferative disorders such as cancer. With a total of 2 patents to her name, her work is paving the way for innovative treatments.
Latest Patents
Her latest patents focus on compounds of Formula I, which are designed to inhibit RAS-effector protein-protein interactions. These compounds are not only relevant for pharmaceutical compositions but also hold promise for treating various diseases where such interactions are implicated. The inventions emphasize the importance of these compounds in addressing critical health challenges.
Career Highlights
Throughout her career, Tenin Traore has worked with esteemed institutions such as The Institute of Cancer Research: Royal Cancer Hospital and Oxford University Innovation Ltd. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the pharmaceutical sector.
Collaborations
Tenin has collaborated with notable professionals in her field, including Terrence Rabbitts and Camilo Quevedo. These partnerships have enhanced her research and expanded the impact of her inventions.
Conclusion
Tenin Traore's innovative work in pharmaceutical compounds showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against cancer and other proliferative disorders.